Cryan S[au] - Search Results

Year	Number of Results
2003	1
2004	1
2005	2
2006	1
2007	1
2008	2
2009	1
2010	2
2011	10
2012	4
2013	6
2014	7
2015	8
2016	6
2017	7
2018	7
2019	7
2020	9
2021	8
2022	6
2023	0

1

Ion-Triggered Hydrogels Self-Assembled from Statistical Copolypeptides.

Wu B, Hanay SB, Kimmins SD, Cryan SA, Hermida Merino D, Heise A. Wu B, et al. Among authors: cryan sa. ACS Macro Lett. 2022 Mar 15;11(3):323-328. doi: 10.1021/acsmacrolett.1c00774. Epub 2022 Feb 16. ACS Macro Lett. 2022. PMID: 35575374 Free PMC article.

2

All trans retinoic acid as a host-directed immunotherapy for tuberculosis.

Bahlool AZ, Grant C, Cryan SA, Keane J, O'Sullivan MP. Bahlool AZ, et al. Among authors: cryan sa. Curr Res Immunol. 2022 Mar 30;3:54-72. doi: 10.1016/j.crimmu.2022.03.003. eCollection 2022. Curr Res Immunol. 2022. PMID: 35496824 Free PMC article. Review.

3

High-content analysis for drug delivery and nanoparticle applications.

Brayden DJ, Cryan SA, Dawson KA, O'Brien PJ, Simpson JC. Brayden DJ, et al. Among authors: cryan sa. Drug Discov Today. 2015 Aug;20(8):942-57. doi: 10.1016/j.drudis.2015.04.001. Epub 2015 Apr 20. Drug Discov Today. 2015. PMID: 25908578 Review.

4

Development and clinical translation of tubular constructs for tracheal tissue engineering: a review.

Soriano L, Khalid T, Whelan D, O'Huallachain N, Redmond KC, O'Brien FJ, O'Leary C, Cryan SA. Soriano L, et al. Among authors: cryan sa. Eur Respir Rev. 2021 Nov 8;30(162):210154. doi: 10.1183/16000617.0154-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34750116 Free PMC article. Review.

5

'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.

Ramsey JM, Hibbitts A, Barlow J, Kelly C, Sivadas N, Cryan SA. Ramsey JM, et al. Among authors: cryan sa. Ther Deliv. 2013 Jan;4(1):59-76. doi: 10.4155/tde.12.133. Ther Deliv. 2013. PMID: 23323781 Review.

6

Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases.

Hassan T, McKiernan PJ, McElvaney NG, Cryan SA, Greene CM. Hassan T, et al. Among authors: cryan sa. Expert Rev Anti Infect Ther. 2012 Mar;10(3):359-68. doi: 10.1586/eri.11.175. Expert Rev Anti Infect Ther. 2012. PMID: 22397568 Review.

7

Modified poly(L-lysine)-based structures as novel antimicrobials for diabetic foot infections, an in-vitro study.

Grace A, Murphy R, Dillon A, Smith D, Cryan SA, Heise A, Fitzgerald-Hughes D. Grace A, et al. Among authors: cryan sa. HRB Open Res. 2022 Jan 12;5:4. doi: 10.12688/hrbopenres.13380.1. eCollection 2022. HRB Open Res. 2022. PMID: 36017374 Free PMC article.

8

Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives.

O'Neill HS, Gallagher LB, O'Sullivan J, Whyte W, Curley C, Dolan E, Hameed A, O'Dwyer J, Payne C, O'Reilly D, Ruiz-Hernandez E, Roche ET, O'Brien FJ, Cryan SA, Kelly H, Murphy B, Duffy GP. O'Neill HS, et al. Among authors: cryan sa. Adv Mater. 2016 Jul;28(27):5648-61. doi: 10.1002/adma.201505349. Epub 2016 Feb 3. Adv Mater. 2016. PMID: 26840955 Review.

9

Three-dimensionally printable shear-thinning triblock copolypeptide hydrogels with antimicrobial potency.

Murphy R , Kordbacheh S , Skoulas D , Ng S , Suthiwanich K , Kasko AM , Cryan SA , Fitzgerald-Hughes D , Khademhosseini A , Sheikhi A , Heise A . Murphy R , et al. Among authors: cryan sa. Biomater Sci. 2021 Aug 7;9(15):5144-5149. doi: 10.1039/d1bm00275a. Epub 2021 Jul 8. Biomater Sci. 2021. PMID: 34236349

10

Respiratory Tissue Engineering: Current Status and Opportunities for the Future.

O'Leary C, Gilbert JL, O'Dea S, O'Brien FJ, Cryan SA. O'Leary C, et al. Among authors: cryan sa. Tissue Eng Part B Rev. 2015 Aug;21(4):323-44. doi: 10.1089/ten.TEB.2014.0525. Epub 2015 Mar 3. Tissue Eng Part B Rev. 2015. PMID: 25587703 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results